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Abstract The transmembrane receptor CD44 conveys
important signals from the extracellular microenvironment
to the cytoplasm, a phenomena known as ‘‘outside-in’’
signaling. CD44 exists as several isoforms that result from
alternative splicing, which differ only in the extracellular
domain but yet exhibit different activities. CD44 is a
binding partner for the membrane-cytoskeleton cross-linker
protein ezrin. In this study, we demonstrate that only CD44
standard (CD44s) colocalizes and interacts with the actin
cross-linkers ezrin and moesin using well-characterized
cell lines engineered to express different CD44 isoforms.
Importantly, we also show that the association CD44s-
ezrin-actin is an important modulator of Fas-mediated
apoptosis. The results highlight a mechanism by which
signals from the extracellular milieu regulate intracellular
signaling activities involved in programmed cell death.
Keywords CD44  Ezrin  Apoptosis 
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Introduction
CD44 is a ubiquitously expressed cell adhesion trans-
membrane receptor which exists as different isoforms. The
large number of isoforms results from alternative splicing
of the extracellular domain, while all isoforms retain a
common transmembrane and intra-cytoplasmic domain.
Post-translational modifications (such as glycosylation) of
the extracellular domain and alternative splicing are known
to influence CD44 function, but nonetheless do not com-
pletely explain the multifunctional activity of CD44.
Many studies have reported the ability of the CD44
cytoplasmic domain as critical in coordinating signaling
events. Indeed, signaling via CD44 can induce the activa-
tion of focal adhesion kinase and mediate resistance to
apoptosis [1]. CD44 may also associate with protein kin-
ases, enhance T cell receptor signaling and thereby support
proliferation, or cell death [2]. CD44 expression and liga-
tion can promote actin cytoskeleton rearrangement during
T cell activation [3]. The carboxy terminal cytoplasmic
domain of CD44 supports the binding of proteins with
crucial functions in cytoskeletal organization and signaling
(reviewed in [4]). These proteins include ankyrin [5],
annexin II [6] and members of the ERM (Ezrin, Radixin,
Moesin, Merlin) family [7–10]. ERM proteins act as cross-
linkers between actin cytoskeleton and membrane
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receptors [11]. ERM proteins can become activated either
by phospholipid binding by their N-terminal domain or by
phosphorylation of C-terminal threonine residue [9, 10].
Once in their ‘‘open and active’’ conformation, the ERM C-
terminal domain can bind actin cytoskeleton, while the N-
terminal domain is able to associate with a number of
transmembrane receptors, including CD44 [11, 12]. These
linker proteins have been shown to localize to membrane
ruffles, microvilli, filopodia and cleavage furrows [11]. In
addition to their structural function, they have been
implicated in several cellular functions that involve actin
cytoskeleton rearrangement, including cell polarization,
migration, morphology, survival and apoptosis [13–18].
The prototype member of the ERM protein family is ezrin.
Ezrin and CD44 are ubiquitously expressed and associate via
the binding of ezrin to the cytoplasmic domain of CD44,
proximal to the transmembrane domain [9]. This association
may function to regulate its subsequent interactions with
downstream signaling pathways (reviewed by [7]). Phos-
phorylation of serine 291 by protein kinase C (PKC), and
dephosphorylation of serine 325 in the cytoplasmic tail of
CD44 result in dissociation of ezrin, and promote cell
migration [18]. In myeloid cells, the binding of phosphory-
lated ERM proteins to CD44 regulates hyaluronan binding to
CD44 [19]. Supporting this idea, reports in other cell types
suggest that phosphorylated ERM and CD44 play a critical
role in microvilli formation, cell adhesion and cell migration
[16, 17]. Confocal microscopy studies on endothelial cells
show colocalization of CD44, ERM proteins, actin filaments
and PKC during wound healing [20]. Recruitment of ezrin
and the actin cytoskeleton by CD44 has also been shown to
be required for c-met signaling and activation of Ras [21]. In
contrast, a recent study reveals that merlin, a member of the
ERM family suppresses tumor growth by inhibiting CD44-
hyaluronic acid interaction [22].
Actin stabilization and destabilization have both been
shown to be implicated in regulation of apoptosis [23–25].
Many reports also suggest that ERM proteins regulate the
initial phase of apoptosis through their effects on the actin
cytoskeleton rearrangement. Indeed, it has been demon-
strated that formation of blebs and disruption of nuclear
integrity during apoptosis requires an intact actin cyto-
skeleton, and that actin accumulates at the basis of the
apoptotic bodies [25]. All these studies together suggest that
membrane receptors, actin cross-linker proteins and cyto-
skeleton remodeling are tightly regulated and implicated in
the control of the cell’s fate. Nonetheless, the impact of
CD44 on the actin cytoskeleton, via its effector protein
ezrin, has not been elucidated in the context of apoptosis.
Recently, we showed that CD44 variant (CD44v) isoforms
block Fas mediated apoptosis [26] whereas the shorter
standard isoform (CD44s) does not. This mechanism
explains the different behavior of CD44s and CD44v
observed during apoptosis induction. Here, we extend these
studies, investigating the interaction between ERM proteins
and different CD44 isoforms, in Jurkat cells in the context
of cell death. Our results implicate CD44-ERM interaction
as an important regulator of Fas-mediated killing.
Material and methods
Cell lines and generation of CD44 transfectants
Jurkat cells (human T cell leukemia line) obtained from the
American Type Culture Collection (ATCC) were co-
transfected by electroporation as described in [26] with a
neomycin resistance plasmid and CD44s, CD44v or CD44s
lacking the cytoplasmic domain (CD44sDcyt) encoding
DNA. The constructs contain EGFP (enhanced green flu-
orescence protein) fused at the CD44 carboxy terminal end
(Fig. 1A).
Expression of CD44 isoforms was confirmed by flow
cytometry with fluorescently labeled antibodies for
panCD44 and CD44v isoforms. Cells with similar green
fluorescence intensity were sorted on a MoFlo high-speed
cell sorter (DakoCytomation, Zug, Switzerland).
Cytochalasin D treatment
Cells were exposed to 0.5 lg/ml of cytochalasin D (CD,
Sigma) for 90 min before apoptosis induction for 5 h with
FasL. The short-term treatment used in this study inhibits
actin polymerization without general cytotoxicity, as
assessed by analytical cytology analyses [27]. Apoptosis
was evaluated by flow cytometry by measuring the sub G1
population.
Induction and evaluation of apoptosis
FasL and anti-human Fas treatment
As previously described [26], Neuro-2a cells producing
recombinant mouse FasL were kindly provided by A.
Fontana (University Hospital, Zu¨rich, Switzerland). Jurkat
transfectants (5 · 105 cells/ml) were incubated with serial
dilutions of FasL or with a Fas cross-linking antibody
(100 ng/ml) (clone 7C11, Immunotech, Marseille, France)
for 1, 3 or 6 h at 37C.
Untreated and Fas triggered cells were collected, and
evaluated for apoptosis with different methods.
1. AnnexinV/PI. Cells were stained with annexinV
labeled with allophycocyanine (APC) (Alexis, Basel,
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Switzerland) and 5 lg/ml propidium iodide (PI)
(Sigma, Buchs, Switzerland) and percentage of apop-
totic cells was evaluated as described in [26].
2. Hypodiploid DNA. Cells were incubated overnight, at
4C, in the dark in a hypotonic DNA binding buffer
(see description in [28]). Apoptotic rates of untreated
and FasL treated cells were compared by flow
cytometry. Apoptosis was evaluated by measuring
loss of PI staining (corresponding to the subdiploid
DNA population also called subG1 population which
represents the apoptotic population) [28].
3. PARP p85. Cells were treated as described in [26] and
percentage of apoptotic cells was evaluated by flow
cytometry by measuring the PE positive cells.
The data obtained from these three methods were ana-
lyzed with the CellQuest program (Becton Dickinson).
Fig. 1 Expression of CD44
isoforms in Jurkat transfectants
and CD44s/ezrin colocalization.
(A) Scheme of the different
CD44-EGFP constructs used for
transfection of Jurkat cells.
Jurkat cells transfected with
CD44s (B), CD44sDcyt (C) and
CD44v2-10 (D). Cells were
stained with anti-panCD44
antibody (Hermes-3), followed
by Cy2 labeled goat anti-mouse
antibody (green fluorescence)
and with anti-ezrin antibody
followed by TxR labeled goat
anti-rabbit antibody. The merge
in yellow represents
colocalization between CD44s
and ezrin. The 2D histograms
display the voxel pattern of
colocalization between CD44
and ezrin. (E) Histogram
representing the percentage of
colocalization between CD44
and ezrin (black bars) and ezrin
and actin (gray bars). Data are
means of three to four data sets
and were analyzed with the
student t-test, (*P \ 0.05;
**P \ 0.01)
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Confocal microscopy
For confocal analysis Jurkat CD44s, Jurkat CD44sDcyt and
Jurkat CD44v cells were washed in PBS, fixed 20 min at
room temperature with 2% PFA, washed twice with PBS and
permeabilized 10 min on ice with 1% triton. Staining was
performed with mouse monoclonal anti-human pan-CD44
(Hermes 3) followed by secondary goat anti-mouse labeled
with Cy2 (Amersham). Cells were washed and also stained
with rabbit anti-human ezrin antibody (Cell signaling,
Allschwil, Switzerland) followed by secondary goat anti-
rabbit labeled with TxR fluorochrome (Southern Biotech-
nology, Reinach, Switzerland). Incubations with the
antibodies were performed on ice, in the dark, during 1 h and
the cells were extensively washed with PBS between the
different steps. All antibodies were diluted in PBS with 1%
BSA. After staining, the cells were spun onto slides (Cyto-
spin) and mounted in Mowiol. For quantitative
colocalization, cells were grown on fibronectin-coated cov-
erslips and immunoreacted as described above. Confocal
image stacks were recorded on a Nikon confocal microscope
operating in the simultaneous acquisition mode. Images
were recorded without clipping of the dynamic range, with
detector settings calibrated to the brightest signal (CD44s)
and analyzed for colocalization using the Imaris software
package (Bitplane AG, Zu¨rich). After application of a
3 · 3 · 3 median filter preventing the formation of noise
induced, single voxel signal in the colocalization maps [29],
a region of interest corresponding to the CD44 signal was
defined by masking the datasets with a threshold at 5% of
maximum green intensity. Thresholds for colocalization
were picked automatically by an algorithm excluding
intensity pairs that exhibit no correlation (Pearson’s coeffi-
cient \ 0) [30] and corrected manually in a few cases with
thresholds below the noise level (8% of maximum inten-
sity). Quantification included determination of colocalized
volume and Pearson’s correlation coefficient, which has the
advantage of being independent of background.
SDS-PAGE and western blotting
As described in [26], Jurkat cells were collected, lysed in
RIPA buffer and extracts were separated on 10% SDS
polyacrylamide gels. Proteins were transferred to poly-
vinylidene fluoride (PVDF) membranes (Schleicher and
Schuell, Dassel, Germany) and blocked for 1 h at room
temperature in PBS with 3% Top Block (Juro, Luzern,
Switzerland). Expression of CD44, ezrin, and tubulin were
detected with mouse monoclonal anti-human CD44 (clone
Hermes 3, kindly provided by E. Butcher, Stanford, CA),
mouse monoclonal anti-human ezrin (clone 18, Transduc-
tion Laboratories, Basel, Switzerland), mouse monoclonal
anti-tubulin (clone 236-10501, Molecular Probes, Leiden,
The Netherlands), followed by goat anti mouse-HRP
(Pierce). The signal was visualized by chemoluminescence
with Super Signal Substrate (Pierce).
Nitrogen cavitation bomb
A total of 108 cells were collected, washed with PBS,
centrifuged 5 min at 1,300 rpm and incubated for 30 min
at 4C on a rotating wheal with magnetic beads coated
with a secondary goat anti-mouse IgG antibody (Dynal,
Hamburg, Germany). The beads were consecutively
coated with anti-panCD44 antibody (clone Hermes 3)
according to the manufacturer’s protocol. The cells coated
with beads were then treated with FasL for 10 min at
37C or left untreated, washed with ice cold H-Buffer
(250 mM sucrose, 10 mM Na-Hepes pH 7.2, 2 mM
MgCl2, 10 mM NaF, 1 mM sodium vanadate) and
retrieved with a magnetic device (Dynal) several times.
The cells coated with the beads were then surface cross-
linked for 2 h at 4C in a rotating wheel with 1 mg/ml
DTSSP [3,3’-Dithiobis-(sulfosuccinimidylpropionate)]
(Pierce). Cross-linking was stopped by incubating the
cells with 20 mM Tris-HCl pH 7.5 for 15 min on ice.
Cells were intensively washed in H-Buffer, resuspended
in H-Buffer+ (H-Buffer with 6.6 lM Pervanadate and
1 mini tablet of a protease inhibitor cocktail (Roche,
Penzberg, Germany) for 10 ml of solution. The number of
cells coated with beads was counted under the microscope
and approximately 40 · 105 cells per sample were dis-
rupted in a nitrogen cavitation bomb at 196C and
600 psi (pounds per square inch) [31]. After disruption of
the membranes, the samples were washed and retrieved
four times and finally resuspended in 2· SDS sample
buffer. For further western blotting analysis, the extracts
were processed as described above and immunoblotted
with mouse monoclonal anti-ezrin antibody (Transduction
Laboratories) followed by goat anti mouse-HRP (Pierce).
The signal was visualized by chemoluminescence
(Pierce).
Results
CD44s and ezrin colocalize and interact together
To determine if ezrin interacts with any isoform of CD44
during apoptosis, we used the Jurkat cell model previously
established which selectively express different CD44 iso-
forms. Jurkat cells normally express Fas, but not CD44,
constitutively and can easily be induced to undergo apop-
tosis with FasL or a Fas cross-linking antibody (clone
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7C11). Our Jurkat cell lines stably expressed cDNA con-
structs for CD44s (Ju CD44s), CD44v2-10 (Ju CD44v2-
10), CD44v3 (Ju CD44v3), CD44v6 (Ju CD44v6), CD44v9
(Ju CD44v9) and CD44sDcyt (Ju CD44sDcyt) (Fig. 1A).
As a control we used Jurkat cells transfected with the
neomycin resistance plasmid alone (Ju neo). Transfected
cells were analyzed by flow cytometry for CD44, Fas and
ezrin expression levels (data not shown). Only cell lines
with comparable CD44, Fas and ezrin levels were used for
these studies.
Confocal data sets of the cells were analyzed for co-
localization. CD44s showed considerable overlap between
CD44 and ezrin which was found predominantly at the
plasma membrane (yellow merge) (Fig. 1B) and which
contained 32% (vol/vol) of the green signal. Accordingly,
the 2D histogram displayed a distinct distribution of voxels
arranged in a diagonal pattern, thus indicating colocaliza-
tion. Ezrin interacts with the cytosolic domain of CD44,
accordingly, colocalization between CD44sDcyt and ezrin
was strongly decreased (Fig. 1C). Thus, the cytosolic
domain is critical for recruitment of ezrin to CD44.
Surprisingly, only 10% of the CD44v2-10 isoform,
which shares the cytoplasmic domain with CD44s,
showed overlap with ezrin (Fig. 1D). Both constructs,
CD44sDcyt and CD44v, displayed histograms with voxels
arranged along the two axes and lacking the diagonal
distribution (Fig. 1C and D). In addition, correlation
coefficients, which provide a measure for the linear
intensity relationship of two channels (1 = absolute linear
relation, 0 = no relation), are quite high in CD44s (0.864)
and show significant decreases in CD44sDcyt and CD44v
that paralleled the results using volumetric data, as shown
in Fig. 1E. We observed a strong colocalization between
CD44s, ezrin or actin but this colocalization did no longer
exist when we substituted the standard form of CD44
(CD44s) by the variant isoform (CD44v2-10) or the
CD44sDcyt isoforms (Fig. 1E). Moreover, CD44sDcyt, as
well as CD44v, displayed colocalization parameters in the
range of those observed in Jurkat neo cells used as neg-
ative control (data not shown). Our results clearly support
a molecular interaction between ezrin, actin and the
cytoplasmic domain of CD44s, but not CD44v. Therefore,
while the cytosolic domain of CD44 may be necessary for
interaction with ezrin, it is insufficient to mediate this
interaction. Jurkat cells also express moesin, and the
active phosphorylated forms of ezrin and/or moesin
(Unpublished observations) are detected in these cells.
When Jurkat transfectants were stained with either anti-
moesin or anti-phospho-ERM (pERM) specific antibodies,
we observed a strong colocalization between CD44s and
moesin or pERM. No colocalization was observed with
CD44v or CD44sDcyt (Unpublished observations).
Together, these results support the notion that active
forms of ezrin, and likely moesin, interact with actin and
the cytosolic domain of CD44s.
To extend and confirm these results, we performed co-
immunoprecipitation experiments using the nitrogen cavi-
tation bomb method. This alternative procedure to
‘‘standard’’ co-immunoprecipitations offers the advantage
that it is detergent-free, and therefore provides an excellent
method to examine protein interactions among membrane
proteins found in lipid rafts [31]. To study the interaction
between CD44 and ezrin, we targeted CD44 in Jurkat neo,
Jurkat CD44s, Jurkat CD44v2-10, v3, v6, v9 and Jurkat
CD44sDcyt cells by cavitation bomb extractions, followed
by immunoblotting with anti-ezrin antibody (Fig. 2A). An
interaction was readily observed with the CD44s isoform,
Fig. 2 Interaction between CD44s and ezrin. (A) Western blotting
for ezrin on CD44 cavitation bomb extractions from Jurkat neo, Jurkat
CD44s, Jurkat CD44v3, Jurkat CD44v6, Jurkat CD44v9, and Jurkat
CD44sDcyt. Cells were incubated with magnetic beads coated with
mouse anti-human CD44 antibody. (B) Western blotting for ezrin on
CD44 cavitation bomb extractions from Jurkat neo, Jurkat CD44s,
and Jurkat CD44v2-10, untreated or treated for 15 min with FasL,
before nitrogen cavitation bomb extraction. (C) Western blotting
showing the expression of panCD44, ezrin and tubulin as a loading
control in the different transfectants
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yet not with other isoforms of CD44. Furthermore, anti-
CD44 cavitation bomb extractions from Jurkat neo, Jurkat
CD44sDcyt and Jurkat CD44v2-10 did not yield any evi-
dence of interaction with ezrin.
These studies were reproduced under two different
conditions: cells untreated and cells treated with FasL for
15 min (Fig. 2B). An 80 kDa band corresponding to ezrin
was evident in the extracts from Ju CD44s cells treated
(and untreated) with FasL. A band at 50 kDa correspond-
ing to the heavy chain of the antibody coupled to the
magnetic beads was observed in all the samples, suggesting
that equal quantities of immunprecipitants were analyzed
in each case. As an additional control, we confirmed that
equal expression of CD44 was maintained in all transfec-
tants via immunoblotting (Fig. 2C). These data confirm
that ezrin interacts selectively with the intracellular domain
of CD44s and that this interaction is present when the cells
are induced to undergo apoptosis with FasL. Interestingly,
all CD44 isoforms share an identical cytoplasmic domain,
thus it is particularly intriguing that interaction between the
CD44v isoforms and ezrin was not observed.
Cells expressing CD44sDcyt are more resistant to Fas
mediated apoptosis
To understand the role of the CD44 cytoplasmic domain in
apoptosis induction we conducted in vitro functional assays
using Jurkat neo, Jurkat CD44s, Jurkat CD44sDcyt and
Jurkat CD44v2-10 transfected cells. We analyzed Jurkat
cells expressing CD44s, which interacts with ezrin together
with Jurkat CD44v2-10 as a characterized negative control
for cell apoptosis in our model [26], and Jurkat CD44sDcyt as
a negative control for ezrin interaction. The different trans-
fectants were treated with a Fas cross-linking antibody for 1,
3, or 6 h, and apoptotic cells were detected by AnnexinV/PI
staining (Fig. 3A). The control cell Jurkat CD44v2-10 was
highly protected from Fas-mediated apoptosis as previously
described [26]. Interestingly, Ju CD44sDcyt cells were also
significantly more resistant to apoptosis than Ju CD44s cells.
In fact, after 3 and 6 h treatment with Fas cross-linking
antibody, Ju CD44sDcyt showed only 7 and 15% of apoptotic
cells, respectively. Ju CD44s and Ju neo cells exhibited
higher rates of cell death, about 20% at 3 h induction and
35% at 6 h induction (Fig. 3A). Similar results were
obtained by measuring hypodiploid DNA after treating the
cells for 3 and 6 h with FasL (Fig. 4B). Indeed, after 6 h
treatment we observed 38% of apoptotic cells in the Ju
CD44s but only 15% in the Ju CD44sDcyt cells. We obtained
similar results when the cells were treated with FasL
(Fig. 3C) or a Fas cross-linking antibody for 3 or 6 h
(Fig. 3D) and the amount of apoptotic cells was detected by
quantifying PARP cleavage. JuCD44s exhibited 41.6% of
apoptotic cells, whereas JuCD44sDcyt showed only 19.2%
(Fig. 3D). These results suggest that the deletion of the
cytoplasmic domain of CD44s plays a critical role in gov-
erning the susceptibility of cells to undergo apoptosis.
Cells expressing CD44s show reduced apoptosis after
treatment with cytochalasin D
Others have described that the cytoplasmic domain of
CD44 can interact with the actin cytoskeleton via linker
proteins such as the ERM proteins [7–9]. To examine the
relevance of the actin cytoskeleton during apoptosis, we
examined the impact of depleting F-actin prior to treating
the different transfectants with Fas. Jurkat cells expressing
CD44s, CD44sDcyt and CD44v2-10 were either treated for
5 h only with FasL or briefly pre-treated with the inhibitor
of actin polymerization Cytochalasin D (CD), then exposed
for 5 h to FasL to induce apoptosis. Similar amounts of
apoptotic cells were observed in the Ju neo, Ju CD44v2-10,
and Ju CD44sDcyt before and after treatment with CD
(Fig. 4A). However, although all Jurkat transfectants
express similar levels of Fas, only Ju CD44s showed a
significant decrease in apoptosis from 35 to 18%, when
they were pre-treated with CD (Fig. 4A). Interestingly, we
could decrease apoptosis either by deleting the cytoplasmic
domain of CD44s or by disrupting the actin cytoskeleton
(Fig. 4A, gray bars, CD44s vs. CD44sDcyt). The data
implicate that the actin-CD44s interaction is critical in
inducing apoptosis, and that disruption of the actin cyto-
skeleton affects the pro-apoptotic effect of CD44s. When
the cytoskeleton was disrupted with CD prior to apoptosis
induction, Ju CD44s cells showed a much lower increase in
apoptosis, only 16.5% of apoptotic cells (Fig. 4B, second
row, third panel) compared to 34.7% observed in the
absence of CD (Fig. 4B, second row, middle panel). CD
treatment had no influence on the apoptosis susceptibility
of Ju neo, Ju CD44sDcyt, and Ju CD44v2-10 (Fig. 4B, first,
third, and fourth row). In the presence or absence of CD, all
three transfectants exhibit similar rates of apoptosis.
Together, these results suggest that the cytoplasmic domain
of CD44s but not the one of CD44v is required for actin
organization and consequently apoptosis induction.
Discussion
CD44s–actin interaction is required for Fas-mediated
apoptosis
Many of the direct interactions between ERM proteins and
transmembrane proteins involve adhesion receptors. ERM
proteins were first found to interact with the cell adhesion
2056 Apoptosis (2007) 12:2051–2061
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receptor CD44 [7, 8] through a positively charged juxta-
membrane region in the CD44 cytoplasmic domain [9].
The interaction between ezrin and CD44 is tightly regu-
lated by Rho GTPases [6] and PKC [18]. The ability of
ezrin to interact with CD44 in a highly regulated fashion
strongly indicates that ezrin might have a role in regulating
cytoskeleton rearrangement. In this report, we demonstrate
that ezrin differentially binds to CD44 isoforms. All iso-
forms share a common cytoplasmic domain and a different
extracellular domain. Here we show that ezrin only colo-
calizes with the CD44s, but not with CD44 lacking the
cytosolic domain or CD44v.
A similar behavior has been observed in other cell
adhesion molecules such as integrins. Integrins are also
subjected to alternative splicing and exist in various iso-
forms differing intra- and extra-cellularly. Interestingly,
ligation of integrins with substrate ligands leads to actin
polymerization and the formation of stable adhesion com-
plexes, and can promote resistance to Fas-mediated
apoptosis, while antagonism of integrins instead promotes
apoptosis (reviewed in [32]). It is possible that CD44 and
integrins work in an integrated fashion to modulate cellular
predisposition to apoptosis based on the local microenvi-
ronment. Future experiments will address the role of CD44
and integrins in the coordination of susceptibility to pro-
grammed cell death.
Interestingly, differences in the extracellular domains of
integrins, or in the composition of integrin heterodimers,
Fig. 3 Jurkat CD44sDcyt cells are more protected from Fas mediated
apoptosis than Jurkat CD44s. (A) Jurkat neo, Jurkat CD44s, Jurkat
CD44sDcyt and Jurkat CD44v2-10 were treated with Fas cross-
linking antibody for 1, 3 or 6 h. Apoptotic cells were determined with
annexinV/PI staining. Values are given for one experiment represen-
tative of three. (B) Jurkat transfectants were treated with recombinant
FasL for 3 or 6 h. The amount of apoptotic cells was determined by
measuring hypodiploid DNA (hypodiploid DNA = subG1 apoptotic
population). Data are representative of three independent experiments
and were analyzed with the Wilcoxon signed rank test (*P \ 0.05).
(C) Jurkat neo, Jurkat CD44s, Jurkat CD44sDcyt and Jurkat CD44v2-
10 were treated with recombinant FasL for 3 or 6 h. The percentage
of apoptotic cells was determined by flow cytometry with an antibody
recognizing the cleaved form of PARP followed by a secondary
antibody labeled with PE. Apoptosis was calculated by subtracting the
control values (between 2 and 4%) from the values obtained with
FasL treatment. Data are representative of three independent exper-
iments and were analyzed with the Wilcoxon signed rank test
(*P \ 0.05). (D) FACS analysis of Jurkat CD44s and Jurkat
CD44sDcyt untreated and treated for 3 h with Fas cross-linking
antibody. Percentage of p85 PARP positive cells was evaluated by
flow cytometry with an anti-p85 PARP antibody followed by a
secondary antibody labeled with PE. The bar is limiting the living
cells on the left according to the control. Numbers in the upper right
corner represent the percentage of apoptotic cells
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leads to differences in candidate ligands. Interactions with
extracellular ligands can trigger diverse intracellular sig-
nals and modulate cellular behavior via a process known as
outside-in signaling [33, 34]. Our data provide evidence
that isoforms of CD44 differing only extracellularly can
similarly regulate intracellular signaling events in a distinct
manner and that interaction between CD44s, ezrin, and
actin directly impacts the efficiency of the proapoptotic
signal.
Ezrin can interact with various membrane proteins such
as Fas, E-cadherin, CD43, and CD44. These interactions
lead to ezrin phosphorylation, activation and promote
subsequent actin polymerization required for diverse bio-
logical processes such as cell death, adherens junctions
formation, immunological recognition, and/or microbial
pathogenesis [35–38]. Interestingly, the interaction of the
death receptor Fas with ezrin has been suggested to be
required for apoptosis induction (reviewed in [39]). Our
results show that the interaction of ezrin to CD44s leads to
similar events observed when ezrin interacts with Fas. The
linkage of CD44 to the actin cytoskeleton mediated by
ezrin, is required for the polarization of the cell preceding
apoptosis signaling (Fig. 5). Our study conditions did not
permit us to duplicate the interaction between Fas and ezrin
Fig. 4 Disruption of the actin
cytoskeleton protects Jurkat
CD44s cells from Fas mediated
apoptosis. (A) Jurkat
transfectants were either treated
for 5 h only with recombinant
FasL or pre-treated for 90 min
with Cytochalasin D (CD)
followed by 5 h treatment with
FasL. Apoptotic cells were
evaluated by measuring
hypodiploid DNA. Data are
representative of three
independent experiments and
were analyzed with the
Wilcoxon signed rank test
(*P \ 0.05). (B) FACS analysis
of Jurkat neo, Jurkat CD44s,
Jurkat CD44sDcyt and Jurkat
CD44v2-10 untreated cells,
treated with FasL for 5 h or pre-
treated with Cytochalasin D
(CD) for 90 min followed by
incubation for 5 h with FasL.
The numbers in the quadrants
represent the percentage of
apoptotic cells obtained in one
experiment representative of
three. The percentage of
apoptotic cells was evaluated by
measuring hypodiploid DNA
(hypodiploid DNA = subG1
apoptotic population). The bar
is limiting the living cells on the
right according to the control
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reported by others, (data not shown), however this could be
due to differences in interacting partner affinities or dif-
ferences in cell type. In our system, both CD44 and Fas are
present and ezrin/moesin would almost certainly engage in
a higher affinity interaction with CD44 than Fas. Regard-
less of which membrane receptor ezrin or moesin interact
with (Fas or CD44), the consequences are identical. In both
cases the interaction of ezrin or moesin with CD44 or Fas
leads to actin organization and is crucial for maintaining
susceptibility to Fas-mediated apoptosis.
In general, the connection between cell membrane pro-
teins and actin, via the ERM proteins, appears to be a key
regulator of cell homeostasis. From a metabolic perspec-
tive, it would seem to be more efficient and probably
easier, for a cell to exploit the capacity to concentrate
proteins in a specific site rather than synthesizing addi-
tional protein de novo.
CD44 regulates apoptosis
One way to explain these observations could be that dif-
ferent ligand binding or extracellular partner(s) may change
the conformation of CD44 or its phosphorylation state, thus
affecting the recruitment of signaling molecules and the
anchorage of the cytoskeleton. In a previous report we have
demonstrated that CD44v isoforms but not CD44s, interact
with the death receptor Fas and, inhibit the death-signaling
cascade [26]. Hence, it is very likely that CD44v isoforms
have a higher affinity for Fas. Tight interactions with Fas
might reasonably be expected to prevent the interaction
with ezrin. This may provide one explanation for the con-
troversial literature surrounding CD44, which has been
described as both a pro-apoptotic molecule [40–42], and an
anti-apoptotic and pro-metastatic protein [43–47]. The
present study together with our previous data [26] provide
one explanation for this controversy. We suggest, on the one
hand that CD44v isoforms, which are upregulated early in
thymic development [48] and later during conditions such
as chronic inflammations and cancer, exhibit an anti-
apoptotic effect by sequestering Fas [26]. On the other hand,
we show that the standard form of CD44 selectively inter-
acts with ezrin/moesin and the actin cytoskeleton forming a
multimeric complex, that maintains or enhances suscepti-
bility to apoptosis (Fig. 5). We also demonstrate that the
CD44sDcyt construct, which is similar to the naturally
spliced isoform expressing a short cytoplasmic tail of only
three amino acids, exerts an anti-apoptotic effect.
In contrast to CD44v, the CD44s isoform lacking the
cytosolic domain does not interact with Fas (data not
shown). Here we document a different anti-apoptotic
mechanism; the CD44s truncated form exerts a protective
effect towards cell death due to its inability to organize the
actin cytoskeleton. Hence, the isoforms of CD44 can
exhibit different and even opposite functions concerning
regulation of cell death and can regulate apoptosis by
diverse mechanisms.
These findings provide an enhanced understanding of the
mechanisms by which CD44 regulates apoptosis, and pro-
vide new information concerning the function of the CD44s
‘‘truncated’’ isoform. The data demonstrate that potential
therapeutic strategies for cancer or autoimmune diseases
that target CD44 should be very specific. As shown here, the
standard isoform contributes to actin organization, which is
crucial for the efficient induction of Fas-mediated apopto-
sis. Therefore, nonspecific therapies, which target all CD44
isoforms, may be counter-productive.
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